Clinical Report: Automated Large-Scale Assessment of Glaucoma Severity

Overview

GFDC 2 provides an automated method for assessing glaucoma severity and progression using perimetry data. It demonstrated near-perfect agreement with manual assessments.

Background

Glaucoma is a prevalent condition requiring ongoing monitoring. Traditional assessment methods are often subjective and time-consuming, leading to backlogs in patient care. Automated tools like GFDC 2 aim to streamline this process.

Data Highlights

Key Findings

• GFDC 2 achieved complete agreement for static parameters from visual field tests (ICC = 1.000).
• Central visual field defects were accurately classified in all cases (accuracy = 100.0%).
• Longitudinal measures showed high agreement, with ICC values of 0.985 for mean deviation progression and 0.994 for visual field index progression.
• Discrepancies in assessments were minor and infrequent, primarily due to unreliable fields in the proprietary GPA.
• GFDC 2 can identify patients needing urgent assessment, supporting risk-stratified follow-up pathways.

Clinical Implications

GFDC 2 may facilitate timely interventions for patients at risk of progression.

Conclusion

GFDC 2 represents a significant advancement in the automated assessment of glaucoma.

Related Resources & Content

1. Ophthalmic Professional, 2014 -- Glaucoma and Guided Progression Analysis
2. Ophthalmology Management, 2020 -- Efficient perimetry, just in time
3. The Ophthalmologist, 2025 -- A Better Measurement of Glaucoma Progression?
4. Ophthalmology Management, 2014 -- GPA: A Better Way of Looking at Glaucoma
5. European Glaucoma Society, 2025 -- Terminology and guidelines for glaucoma, 6th Edition
6. PubMed -- Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial
7. European Glaucoma Society – Terminology and guidelines for glaucoma, 6th Edition
8. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial - PubMed
9. Diagnostic accuracy and reliability of portable visual field-testing devices for detecting manifest glaucomatous visual-field loss: a systematic review and meta-analysis - PMC